{"id":"https://openalex.org/W4229028011","doi":"https://doi.org/10.1016/j.annonc.2022.03.105","title":"90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)","display_name":"90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)","publication_year":2022,"publication_date":"2022-05-01","ids":{"openalex":"https://openalex.org/W4229028011","doi":"https://doi.org/10.1016/j.annonc.2022.03.105"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2022.03.105","doi":"https://doi.org/10.1016/j.annonc.2022.03.105","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2022.03.105","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2022.03.105","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"G. Rossi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"G. Rossi","raw_affiliation_strings":["Research & Development Department, Breast International Group (BIG) - AISBL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research & Development Department, Breast International Group (BIG) - AISBL, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005973748","display_name":"Etienne G.C. Brain","orcid":"https://orcid.org/0000-0003-0881-9371","observed_orcids":["https://orcid.org/0000-0003-0881-9371"]},"institutions":[{"id":"https://openalex.org/I4210116453","display_name":"H\u00f4pital Ren\u00e9 Huguenin","ror":"https://ror.org/0263jp665","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116453"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Brain","raw_affiliation_strings":["Department of Medical Oncology, Institut Curie - H\u00f4pital Ren\u00e9 Huguenin, Saint-Claud, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Curie - H\u00f4pital Ren\u00e9 Huguenin, Saint-Claud, France","institution_ids":["https://openalex.org/I4210116453","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090009905","display_name":"Amylou Constance Dueck","orcid":"https://orcid.org/0000-0002-9912-1085","observed_orcids":["https://orcid.org/0000-0002-9912-1085"]},"institutions":[{"id":"https://openalex.org/I4210091146","display_name":"Alliance Foundation Trials","ror":"https://ror.org/00fztf021","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210091146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Dueck","raw_affiliation_strings":["Alliance Foundation Trials (AFT), Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alliance Foundation Trials (AFT), Boston, MA, USA","institution_ids":["https://openalex.org/I4210091146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060006475","display_name":"Heidi De Swert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"H. De Swert","raw_affiliation_strings":["Research Operations Department, Breast International Group (BIG) - AISBL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Operations Department, Breast International Group (BIG) - AISBL, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061157288","display_name":"Sandrine I. Marreaud","orcid":"https://orcid.org/0000-0002-3205-3858","observed_orcids":["https://orcid.org/0000-0002-3205-3858"]},"institutions":[{"id":"https://openalex.org/I126419005","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/04g9wby70","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I126419005","https://openalex.org/I4210124801"]},{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE","NL"],"is_corresponding":false,"raw_author_name":"S.I. Marreaud","raw_affiliation_strings":["Medical Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium","institution_ids":["https://openalex.org/I126419005","https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I4210091146","display_name":"Alliance Foundation Trials","ror":"https://ror.org/00fztf021","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210091146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Partridge","raw_affiliation_strings":["Department of Medical Oncology, Alliance Foundation Trials (AFT), Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Alliance Foundation Trials (AFT), Boston, MA, USA","institution_ids":["https://openalex.org/I4210091146"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081376530","display_name":"Christina Isabella Herold","orcid":"https://orcid.org/0009-0002-0177-0253","observed_orcids":["https://orcid.org/0009-0002-0177-0253"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Herold","raw_affiliation_strings":["Oncology, Sanofi Genzyme, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Sanofi Genzyme, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070874628","display_name":"Hugo Vachon","orcid":"https://orcid.org/0000-0003-1259-649X","observed_orcids":["https://orcid.org/0000-0003-1259-649X"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"H. Vachon","raw_affiliation_strings":["Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109509230","display_name":"Tanja \u0160pani\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143573","display_name":"Europa Donna","ror":"https://ror.org/04r1mej53","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210143573"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"T. Spanic","raw_affiliation_strings":["Europa Donna \u2212 the European Breast Cancer Coalition, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Europa Donna \u2212 the European Breast Cancer Coalition, Milan, Italy","institution_ids":["https://openalex.org/I4210143573"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013337676","display_name":"Amal Arahmani","orcid":"https://orcid.org/0009-0005-3752-9957","observed_orcids":["https://orcid.org/0009-0005-3752-9957"]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"A. Arahmani","raw_affiliation_strings":["Research Operations Department, Breast International Group (BIG)-AISBL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Operations Department, Breast International Group (BIG)-AISBL, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024987972","display_name":"Tom Verbiest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126419005","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/04g9wby70","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I126419005","https://openalex.org/I4210124801"]},{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE","NL"],"is_corresponding":false,"raw_author_name":"T. Verbiest","raw_affiliation_strings":["Data Management, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Management, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium","institution_ids":["https://openalex.org/I126419005","https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031843293","display_name":"L. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Wang","raw_affiliation_strings":["Translational Medicine and Early Development, Sanofi, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine and Early Development, Sanofi, Boston, MA, USA","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023200887","display_name":"Theodora Goulioti","orcid":"https://orcid.org/0009-0006-0178-5120","observed_orcids":["https://orcid.org/0009-0006-0178-5120"]},"institutions":[{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"T. Goulioti","raw_affiliation_strings":["Breast International Group (BIG) - AISBL, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast International Group (BIG) - AISBL, Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029881855","display_name":"B. Malanda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126419005","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/04g9wby70","country_code":"NL","type":"nonprofit","lineage":["https://openalex.org/I126419005","https://openalex.org/I4210124801"]},{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE","NL"],"is_corresponding":false,"raw_author_name":"B. Malanda","raw_affiliation_strings":["Projects Direction, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Projects Direction, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium","institution_ids":["https://openalex.org/I126419005","https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041777150","display_name":"LA Carey","orcid":"https://orcid.org/0000-0003-2388-4649","observed_orcids":["https://orcid.org/0000-0003-2388-4649"]},"institutions":[{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.A. Carey","raw_affiliation_strings":["Division of Medical Oncology, North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077127308","display_name":"S. Anneheim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Anneheim","raw_affiliation_strings":["Oncology Development, Sanofi-Aventis Recherche et Developpement, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Development, Sanofi-Aventis Recherche et Developpement, Vitry-sur-Seine, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055747350","display_name":"Gautier Paux","orcid":"https://orcid.org/0000-0003-3002-6351","observed_orcids":["https://orcid.org/0000-0003-3002-6351"]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Paux","raw_affiliation_strings":["Biostatistics and Programming, Sanofi-Aventis U.S. LLC, Bridgewater, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics and Programming, Sanofi-Aventis U.S. LLC, Bridgewater, MA, USA","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006533368","display_name":"Coralie Poncet","orcid":"https://orcid.org/0000-0002-8635-9350","observed_orcids":["https://orcid.org/0000-0002-8635-9350"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"C. Poncet","raw_affiliation_strings":["Statistics, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026132340","display_name":"Otto Metzger","orcid":"https://orcid.org/0000-0003-0792-0320","observed_orcids":["https://orcid.org/0000-0003-0792-0320"]},"institutions":[{"id":"https://openalex.org/I4210091146","display_name":"Alliance Foundation Trials","ror":"https://ror.org/00fztf021","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210091146"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. Metzger","raw_affiliation_strings":["Department of Medical Oncology, Alliance Foundation Trials (AFT), Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Alliance Foundation Trials (AFT), Boston, MA, USA","institution_ids":["https://openalex.org/I4210091146"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007286394","display_name":"David Cameron","orcid":"https://orcid.org/0000-0002-2717-7979","observed_orcids":["https://orcid.org/0000-0002-2717-7979","https://orcid.org/0000-0001-6097-2256"]},"institutions":[{"id":"https://openalex.org/I2800150677","display_name":"Western General Hospital","ror":"https://ror.org/009kr6r15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"]},{"id":"https://openalex.org/I2802581871","display_name":"Edinburgh Cancer Research","ror":"https://ror.org/05a7t9b67","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I2802581871","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I4210158898","display_name":"Institute of Genetics and Cancer","ror":"https://ror.org/05hygey35","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210158898","https://openalex.org/I90344618","https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Cameron","raw_affiliation_strings":["University of Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK","institution_ids":["https://openalex.org/I2800150677","https://openalex.org/I2802581871","https://openalex.org/I4210158898"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4230,"currency":"USD","value_usd":4230},"apc_paid":null,"fwci":0.1612,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44342634,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"33","issue":null,"first_page":"S162","last_page":"S163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.7261000275611877,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.7261000275611877,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.26269999146461487,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8109999895095825},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.968999981880188},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9220714569091797},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.7842265963554382},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6902506351470947},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.6746584177017212},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.6408323049545288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6100669503211975},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6040958166122437},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.584985613822937},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.5256330370903015},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.525018036365509},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.4886491894721985},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.47342637181282043},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4641718864440918},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4544825553894043},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43160784244537354},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4259521961212158},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36704781651496887},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2022.03.105","doi":"https://doi.org/10.1016/j.annonc.2022.03.105","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2022.03.105","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2022.03.105","doi":"https://doi.org/10.1016/j.annonc.2022.03.105","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2022.03.105","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281780516","https://openalex.org/W4322774015","https://openalex.org/W4285592981","https://openalex.org/W4221124594","https://openalex.org/W4220857846","https://openalex.org/W4286508883","https://openalex.org/W4220823416","https://openalex.org/W3167401398","https://openalex.org/W3203814516","https://openalex.org/W3167408526"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-05-08T00:00:00"}